首页 | 本学科首页   官方微博 | 高级检索  
     

丹参对大鼠移植肝血红素氧合酶1表达的影响*
引用本文:高传长,李冬盛,王恺,邹书兵. 丹参对大鼠移植肝血红素氧合酶1表达的影响*[J]. 中国神经再生研究, 2011, 15(31): 5722-5725
作者姓名:高传长  李冬盛  王恺  邹书兵
作者单位:南昌大学第二附属医院,江西省南昌市 330006,南昌大学第二附属医院,江西省南昌市 330006,南昌大学第二附属医院,江西省南昌市 330006,南昌大学第二附属医院,江西省南昌市 330006
基金项目:江西省自然科学基金项目(2007GZY1183)
摘    要:背景:器官移植前使用丹参预处理能够保护组织缺血-再灌注损伤,改善移植器官存活率。目的:观察含丹参的冷灌注液对同种异体大鼠移植肝脏中血红素氧合酶1表达的影响,以及对供体肝脏缺血-再灌注损伤的保护作用。方法:将SD雄性大鼠随机分成UW液组(术中使用UW液灌注保存)、丹参+UW液组(术中使用丹参+UW液灌注保存)、ZnPP预处理组(移植前24 h腹腔内注射ZnPP,术中使用丹参+UW液灌注保存),建立稳定的大鼠同种异体肝移植模型。同时取10只正常大鼠作为正常对照。结果与结论:丹参+UW液组和UW液组血清总胆红素、谷丙转氨酶、谷草转氨酶水平明显低于ZnPP预处理组(P < 0.01)。血红素氧合酶1mRNA及其蛋白在丹参+UW液组中较UW组表达更明显,在ZnPP预处理组中表达明显受到抑制(P < 0.05)。丹参+UW液组肝脏Suzuki标准评分明显低于ZnPP预处理组及UW液组(P < 0.05)。表明丹参能上调同种异体的大鼠移植肝脏中血红素氧合酶1 mRNA及其蛋白的表达,减轻供肝缺血-再灌注损伤,保护移植大鼠肝脏。

关 键 词:血红素氧合酶1;肝移植;丹参;缺血-再灌注损伤;肝脏
收稿时间:2011-04-07
修稿时间:2011-04-07

Effects of Danshen on heme oxygenase-1 expression in rat transplanted liver
Gao Chuan-chang,Li Dong-sheng,Wang Kai and Zou Shu-bing. Effects of Danshen on heme oxygenase-1 expression in rat transplanted liver[J]. Neural Regeneration Research, 2011, 15(31): 5722-5725
Authors:Gao Chuan-chang  Li Dong-sheng  Wang Kai  Zou Shu-bing
Affiliation:Department of Hepatobiliary Surgery, Second Affiliated Hospital of Medical College of Nanchang University, Nanchang 330006, Jiangxi Province, China,Department of Hepatobiliary Surgery, Second Affiliated Hospital of Medical College of Nanchang University, Nanchang 330006, Jiangxi Province, China,Department of Hepatobiliary Surgery, Second Affiliated Hospital of Medical College of Nanchang University, Nanchang 330006, Jiangxi Province, China,Department of Hepatobiliary Surgery, Second Affiliated Hospital of Medical College of Nanchang University, Nanchang 330006, Jiangxi Province, China
Abstract:BACKGROUND: Danshen pretreatment before organ transplantation can protect tissue from ischemia-reperfusion injury and improve the survival rate of graftsOBJECTIVE: To investigate the effects of Danshen-containing cold perfusion solution on heme oxygenase-1 (HO-1) expression in rat liver allograft and the protective effects on donor liver from ischemia-reperfusion injury.METHODS: Sprague-Dawley male rats were randomly divided into University of Wisconsin solution (UW) solution group (UW group, preservation using UW solution during transplantation), Danshen+UW solution group (DS+UW group, preservation with Danshen+UW solution during transplantation), ZnPP (HO-1 inhibitor) pretreatment group (ZnPP group, intraperitoneal injection of ZnPP 24 hours before transplantation, and preservation with Danshen+UW solution during transplantation). Reliable rat models of liver allografting were established. Ten normal rats were selected as normal controls. RESULTS AND CONCLUSION: Serum total bilirubin, alanine aminotransferase, and aspartate aminotransferase levels were significantly lower in the DS+UW group, UW group than in the ZnPP group (P < 0.01). HO-1 mRNA and protein expressions were greater in the DS+UW group than in the UW group, but the expressions were obviously inhibited in the ZnPP group (P < 0.05). Suzuki scores were significantly lower in the DS+UW group than in the ZnPP group and UW group. These findings suggest that Danshen can upregulate HO-1 mRNA and protein expressions in rat liver allograft, alleviate ischemia-reperfusion injury of donor liver, and protect the transplanted liver.
Keywords:liver transplatation    heme oxygenase-1   danshen
点击此处可从《中国神经再生研究》浏览原始摘要信息
点击此处可从《中国神经再生研究》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号